
    
      Study design: Randomized, double-blinded, placebo-controlled, parallel, multi-center study of
      ultramicronized PEA (Normast)with a week of baseline period followed by 1 x 12 weeks
      treatment period.

      Methodology: Given Normast 600mg x 2 daily or corresponding placebo and kept on that dose for
      12 weeks.
    
  